Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Antineoplastic Agents|Antiemetics|Quality of Life
Interventions: DRUG: Palonosetron|DRUG: Ondansetron
Sponsor: Instituto Nacional de Cancerologia de Mexico